[1] 曹旬旬,高月求,张文宏,等. 基于上海市住院慢性肝病患者胆汁淤积患病率的调查研究. 中华肝脏病杂志,2015,23(8):569-573. [2] Chalasani NP,Hayashi PH,Bonkovsky HL,et al. ACG Clinical Guideline:the diagnosis and management of idiosyncratic drug- induced liver injury. Am J Gastroenterol,2014,109(7):950-966. [4] Danan G,Beniehou C.Causality assessment of adverse reactions to drugs-A novel method based on the conclusions of international consensus meetings:application to drug-induced liver injuries.J Clin Epidemiol,1993,46:1323-1330. [5] 中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南. 中华肝脏病杂志,2015,23(11):810-820. [6] European Association for the Study of the Liver. EASL Clinical Practice Guidelines:Management of cholestatic liver diseases. J Hepatol,2009,51(2):237-267. [7] 范作鹏,聂巍,梁珊,等. 北京地区药物性肝衰竭临床特点分析.北京医学,2015,37(9):846-849. [8] Hou FQ,Zeng Z,Wang GQ. Hospital admissions for drug-induced liver injury:clinical features,therapy,and outcomes. Cell Biochem Biophys,2012,64(2):77-83. [9] Andrade RJ,Lucena MI,Kaplowitz N,et al. Outcome of acute idiosyncratic drug-induced liver injury:Long-term follow-up in a hepatotoxicity registry. Hepatology,2006,44(6):1581-1588. [10] 赖荣陶,王晖,桂红莲,等. 138例药物性肝损伤患者的临床特征及肝脏组织学改变. 中华肝脏病杂志,2012,20(3):185-189. [11] Andrade RJ,Lucena MI,Kaplowitz N,et a1.Outcome of acute idiosyncratic drug-induced liver injury:Long term follow up in a hepatotoxicity registry.Hepatology,2006,44(6):1581-1588. [12] 朱雯静,赵新颜,马红. 慢性药物性肝损伤的研究进展.中华肝脏病杂志,2015,23(9):718-720. [13] Russo MW,Galanko JA,Shrestha R,et al. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transplant,2004,10(8):1018-1023. [14] 张义红,张义卫. 熊去氧胆酸治疗老年人胆汁淤积型药物性肝损伤临床疗效分析. 肝脏,2013,18(10):685-686. [15] 陈东风,孙文静,熊吉. 药物性肝损伤的诊断与治疗. 中华肝脏病杂志,2012,20(3):170-172. [16] 朱超慧,董迎华,艾正琳,等. 药物性胆汁淤积型肝病的治疗研究. 胃肠病学和肝病学杂志,2014,23(1):90-93. [17] 明雅南,刘晓琳,茅益民. 药物性肝损伤发病机制研究进展.实用肝脏病杂志,2014,17(6):657-660. [18] 韩平,田德安. 肝内胆汁淤积发病机制及药物治疗新进展. 胃肠病学和肝病学杂志,2016,25(5):584-588. [19] Aithal GP,Watkins PB,Andrade RJ,et a1. Case definition and phenotype standardization in drug-induced liver injury.Clin Pharmacol Ther,2011,89(6):806-815. [20] Borraz Y,Fernandez MC,Garcia-Muhoz B,et al. Would it be desirable to modify the cut-off point for definition of chronicity in drug-induced liver injury (DILI) 61st Annual Meeting of the American Association for the Study of Liver Diseases:2010,A270. [21] Ju HY,Jang JY,Jeong SW,et al. The clinical features of drug-induced liver injury observed through liver biopsy:focus on relevancy to autoimmune hepatitis. Clin Mol Hepatol,2012,18(2):213-218. |